Italy’s Axxam and Molecular Health have partnered to identify and validate new therapeutic targets in drug development.

The Phase III trial, conducted by Chinese license partner Ascletis, produced strong results for denifanstat compared to ...

Redwire Corporation has secured a contract from Aspera Biomedicines to carry out space-based research on a cancer treatment.

Agenus has signed $141m partnership agreements with Zydus Lifesciences and its subsidiaries to enhance clinical developments ...

In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh ...

Already offering the only non-invasive treatment for SMA in liquid form, Roche’s Evrysdi now comes as a tablet.